AAAAAA

   
Results: 1-7 |
Results: 7
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: A Southwest Oncology Group trial (SWOG-9326)
Authors: Rothenberg, ML Liu, PY Wilczynski, S Hannigan, EV Weiner, SA Weiss, GR Hunter, VJ Chapman, JA Tiersten, A Kohler, PC Alberts, DS
Citation: Ml. Rothenberg et al., Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: A Southwest Oncology Group trial (SWOG-9326), GYNECOL ONC, 82(2), 2001, pp. 317-322
A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive
Authors: Muderspach, L Wilczynski, S Roman, L Bade, L Felix, J Small, LA Kast, WM Fascio, G Marty, V Weber, J
Citation: L. Muderspach et al., A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive, CLIN CANC R, 6(9), 2000, pp. 3406-3416
A phase I radioimmunotherapy trial evaluating (90)yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84,66 in patients with metastatic CEA-producing malignancies
Authors: Wong, JYC Chu, DZ Yamauchi, DM Williams, LE Liu, A Wilczynski, S Wu, AM Shively, JE Doroshow, JH Raubitschek, AA
Citation: Jyc. Wong et al., A phase I radioimmunotherapy trial evaluating (90)yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84,66 in patients with metastatic CEA-producing malignancies, CLIN CANC R, 6(10), 2000, pp. 3855-3863
Initial clinical experience evaluating yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer
Authors: Wong, JYC Somlo, G Odom-Maryon, T Williams, LE Liu, A Yamauchi, D Wu, AM Yazaki, P Wilczynski, S Shively, JE Forman, S Doroshow, JH Raubitschek, AA
Citation: Jyc. Wong et al., Initial clinical experience evaluating yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer, CLIN CANC R, 5(10), 1999, pp. 3224S-3231S
Clinical, histopathologic, and molecular aspects of cutaneous human papillomavirus infections
Authors: Fazel, N Wilczynski, S Lowe, L Su, LD
Citation: N. Fazel et al., Clinical, histopathologic, and molecular aspects of cutaneous human papillomavirus infections, DERM CLIN, 17(3), 1999, pp. 521
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: A Southwest Oncology Group study
Authors: Poplin, EA Liu, PY Delmore, JE Wilczynski, S Moore, DF Potkul, RK Fine, BA Hannigan, EV Alberts, DS
Citation: Ea. Poplin et al., Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: A Southwest Oncology Group study, GYNECOL ONC, 74(3), 1999, pp. 432-435
Retinoic acid induces Gpx2 gene expression in MCF-7 human breast cancer cells
Authors: Chu, FF Esworthy, RS Lee, L Wilczynski, S
Citation: Ff. Chu et al., Retinoic acid induces Gpx2 gene expression in MCF-7 human breast cancer cells, J NUTR, 129(10), 1999, pp. 1846-1854
Risultati: 1-7 |